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Abstract
Objectives The aim of the article was to present an overview
of the management strategies of dentin hypersensitivity
(DHS) and summarize and discuss the therapeutic options.
Materials and methods A PubMed literature search
was conducted to identify articles dealing with dentin
hypersensitivity prophylaxis and treatment. We focussed on
meta-analyses of available or controlled clinical trials.
Results DHS therapy should start with noninvasive individual
prophylactic home-care approaches. In-office therapy follows
with nerve desensitizing, precipitating, or plugging agents. If
the hypersensitivity persists, depending on the hard and soft
tissue components at reevaluation, i.e., presence or absence of
cervical lesions and the gingival contour, adhesive restorations
including sealing or mucogingival surgery may be an option.
They allow for the establishment of a physicomechanical
barrier. As the placebo effect may play an important role,
adequate patient management strategies and positive
reinforcement may improve the management of DHS in the
future.
Conclusions Lifelongmaintenance under the premise of strict
control of the causative factors is crucial in the management of
DHS.
Clinical relevance Clinicians are faced with a broad spectrum
of therapeutic options. Therapy should not only focus on pain
reduction or better elimination but also on the modification of
the exposed cervical dentin area based on the defect type.
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Background and aim
Dentin hypersensitivity (DHS) describes a painful symptom
of the exposed and innervated cervical pulp–dentin complex.
Its prevalence greatly varies and ranges from 3 up to 98% and
can be explained—in part—by different evaluation methods
and different patient populations, e.g., patients suffering from
periodontitis [1].
It is important to acknowledge that localized attachment
loss is probably the most widespread and relevant factor
leading to any root surface denudation and dental hard tissue
sequelae, including DHS. Several predisposing factors of
gingival recessions have been identified, e.g., dehiscency or
fenestration of the alveolar bone and soft tissue morphotype,
but triggering pathological, therapeutic, or iatrogenic factors
are also crucial for its development [2]. Loss of dental hard
tissue in the coronal aspect, especially enamel, is considered
an alternative pathway of cervical dentin exposure and is
mainly caused by erosion, abrasion, and abfraction or a com-
bination thereof [2].
DHS is mainly a diagnosis of exclusion. Thus, differential
diagnostic aspects play a pivotal role and a thorough anam-
nestic evaluation is indispensable to identify etiopathogenic
factors [3]. This decision process is important to effectively
control and treat underlying causative and modifying factors
[4].
Different materials andmethods have been described to treat
DHS. Cause-related therapy primarily aims to mechanically or
chemically protect the pulp–dentin complex or to suppress or
modify the nerve stimulation while controlling the predisposing
factors. However, no treatment has been found so far,
which could serve as a defined therapeutic gold standard,
which predictably and completely eliminates pain perception,
especially in the long term. Root canal therapy may be
considered as the last resort, but there is a consensus that this
invasive treatment should not be considered in the first line. In
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contrast, treatment should conceptually start with minimally
invasive and reversible approaches. If these are not successful
at reevaluation, subsequently more invasive and maybe
more expensive or even irreversibe treatment options should
be envisioned. A crucial question is whether or when does
treatment become necessary. Table 1 gives an overview of a
suggested decision tree for intervention and additional
differential diagnosis.
If a patient self-reports pain, the necessity of DHS treatment
is evident. A pain provocation test should then be performed.
Most commonly, air application and/or gentle scratching with a
probe are used for this purpose. If this pain provocation test is
positive and other pathologies can be excluded (differential
diagnosis), DHS therapy should be initiated. In the case of a
negative provocation test, special emphasis should be put on
the differential diagnosis and the cause of the pain should be
carefully evaluated (endodontic or cariologic origin, orofacial
pain, etc.). If a patient reports no hypersensitive episodes, a
provocation test is optional but recommended during routine
dental screening. In the case of exposed cervical areas which
are sensitive upon provocation, a treatment can be considered
in prophylactic terms. In case of a negative provocation test,
any DHS therapy becomes needless. It is important to
acknowledge that not all patients report hypersensitivity
experiences, and dentists and prophylaxis personnel
should therefore screen for DHS on a routine basis.
This article focuses on the current management of DHS.
Different materials and techniques are critically discussed
and future perspectives are shown. Whenever possible,
systematic reviews were used to document the success/
failure of a method.
Current management of DHS
Prevention is better than cure. Thus, primary prevention of
dentin exposure as a result of recession formation and/or
dental hard tissue damage by any prophylactic measures or
erosive/abrasive diet is the best way to actually treat this
phenomenon and its associated painful symptoms [5].
Special focus must thus be set on the prevention of DHS, such
as to avoid erosive drinks or foods and choose nonabrasive
toothbrushes, brushing techniques, etc.
The management of DHS can be generally divided in
two different approaches: self-performed therapy at home
(professionally dispensed self-applied or over the counter)
or in-office treatment. The latter normally applies more
sophisticated noninvasive or invasive methods using
professional materials and techniques. In general, all
interventions should start with noninvasive, reversible,
nonhazardous, easy to perform, and inexpensive options.
Only if they prove to be ineffective at reevaluation
should more invasive interventions be considered.
Conceptually, treatment of DHS aims either to suppress
the nerve impulse by direct neurological interaction or by
mechanical blockage of the tubules. Potassium ions can
decrease the excitability of A fibers, which surround the
odontoblasts, thus resulting in a significant reduction in
tooth sensitivity. Toothpastes for instance contain mostly
5 % potassium nitrate [6], but there is still a debate
concerning its effectiveness [7].
Table 1 Proposed evaluation and decision steps
Fig. 1 SEM image of dentin
treated with a precipitating
agent: Panel a shows treated
(bottom left) and untreated (top
right) areas. However, despite
clear evidence of crystallite
deposition, uncovered dentin
areas and tubule entrances can
be seen (b)
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Aside from nerve desensitization, occlusion of the
dentinal tubules is the main therapeutic approach (Fig. 1).
There is a plethora of agents, materials, and products available
on the market for this purpose. Different mechanisms
can be identified to modify the dentin surface or tubules
by chemical, mechanical, and/or physical means, e.g.,
protein precipitation, plugging of dentin tubules, sealing,
or laser applications.
Aqueous glutaraldehyde-containing solutions have
shown to be effective in reducing dentin hypersensitivity
[8]. They have been shown to close dentinal tubules by
precipitative intratubular occlusion and thereby to a significant
decrease of dentin permeability, even under clinical conditions
[9, 10]. As a positive side effect, glutaraldehyde disinfects
dentin in vitro and seems compatible with adhesive systems
[11, 12]. However, potential biocompatibility hazards should
not be neglected [13, 14].
Different plugging agents have been described and most
products belong to this group of action. Among these, oxalates
have been used to precipitate and occlude the tubules.
Fig. 2 Restitution of the
anatomy of the cervically
exposed dentin using a
restorative approach with an
adhesive class V filling (a/c),
thereby covering and protecting
the sensitive dentin. As an
alternative, a recession
coverage using a connective
tissue graft before can be
indicated, especially if the tooth
substance loss is limited and the
soft tissue morphology is
adequate for a mucogingival
approach (panel b before
treatment and d 1 year after
mucogingival surgery using a
coronally advanced flap and
connective tissue graft)
Fig. 3 Flow chart of the
decision-making process
based on the underlying
defect. Depending on the
dental hard tissue damage
and the morphology of the
surrounding soft tissues
(according to Miller 1985),
an adequate therapy can
be initiated
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However, a systematic review recently revealed that with the
possible exception of 3 % monohydrogen monopotassium
oxalate, available evidence does not currently support the
recommendation of dentin hypersensitivity treatment with
oxalates [15].
Products containing arginine/calcium carbonate, bioactive
glass, or strontium acetate have been introduced in the
market with similar modes of action (occlusion of the
tubule openings) and seem to provide good clinical results and
pain relief [16–18]. The available home-care products should
be considered as the first approach.
xFluoride varnishes have also shown to protect the dentin
surface by forming a protective layer of calcium fluoride
[19–21]. Whereas lasers have been frequently assessed in
the management of DHS, their clinical success is questionable
[22]. However, fluoride gels in combination with laser showed
some cumulative efficacy [23]. Another more exotic approach
is the combination of acidulated fluoride gels with iontophe-
resis [24].
A reliable technique to close dentin tubules is the application
of a chemomechanical barrier between the dentin and the
oral environment based on adhesive bonding techniques [25].
However, most of the bonding agents have no fillers, which
potentially leads to wear in exposed areas [26]. The question is
therefore how effectively can these lesions be resealed.
All methods described above are indicated especially in
cases with limited amounts of dental hard tissue loss, i.e., no
classical abrasive or erosive defect characteristics. In cases
where a class V filling is indicated, an adhesive filling is a
valid option. Regenerative mucogingival therapy also
remains an alternative, where hard and soft tissue conditions
allow [27] (Fig. 2). A suggested strategy for DHS manage-
ment, taking these morphological aspects into consideration,
is depicted in Fig. 3. It should be noted that adequate
diagnosis and prophylactic measures are a prerequisite for
any successful management strategy, which is comple-
mented with a strict long-term maintenance program in
harmony with the special needs of DHS.
Outlook
DHS still is an underestimated problem in daily clinical
practice. Most patients develop coping strategies. However,
especially in cases where we are confronted with moderately
symptomatic and more severe episodes, finding the right
solution is difficult, and trial and error strategies are still
a daily occurrence. Thus, the development of new materials
and methods is greatly needed, including the development of
improved precipitating materials, which effectively bind to the
exposed dentin wound and reduce the outflow of dentinal fluid.
This outflow continues to hamper precipitation or bonding
processes. The use of lasers in combination with such materials
could be beneficial, leading to better precipitation or controlled
melting mechanisms and impregnation.
In addition, as we are dealing with exposed cervical
dental hard tissue areas, a focus also has to be put on
improving the caries resistance of these involved surfaces.
The development of prophylactic measures with less risk of
recession formation or abrasion is also warranted.
Another aspect is the placebo effect, which is an important
and potentially beneficial side effect when dealing with pain,
and its treatment and management. Using arthritis of the knee
as an example in the medical field, it has been impressively
shown that sham endoscopic interventions lead to the same
reduction of pain and symptoms as conventional treatment
modalities [28]. In addition, prescription of differently colored
pills resulted in significant differences in pain reduction
[29]. Whereas a red placebo tablet, for instance, showed
comparable pain relief as the best antirheumatic test pill used,
the blue equivalent showed the least effect. Thus, improved
psychological co-therapeutic strategies may one day become
an important auxiliary aspect in DHS management, especially
when it comes to changing patients’ expectations of treatment
outcomes and confidence. The psychological training of
dental professionals still has some room for development.
Conclusion
DHS is a problem. While there is no necessarily acute
pathological risk for the affected tooth site at the moment,
patients may suffer greatly and future damage due to the
persisting pain challenge and its causative factors, i.e., the
co-etiopathological factors, cannot be excluded. Therefore,
a therapy should not only focus on pain reduction or better
elimination but also on the modification of the exposed
cervical dentin area based on the defect type. Preventive,
restorative, and periodontal options may be individually
indicated to resolve the pain problem, while concomitantly
reducing the risk for future damage to the pulp–dentin
complex. Adequate home-care products are advisable.
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